SomnoMed Limited (SOMNF)
OTCMKTS
· Delayed Price · Currency is USD
0.3852
-0.0162 (-4.04%)
At close: Mar 20, 2025
SomnoMed Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 100.25 | 91.65 | 83.62 | 72.58 | 62.71 | 57.3 | Upgrade
|
| Revenue Growth (YoY) | 12.93% | 9.61% | 15.20% | 15.75% | 9.44% | -2.71% | Upgrade
|
| Cost of Revenue | 40.09 | 36.52 | 31.69 | 28.3 | 24.96 | 24.2 | Upgrade
|
| Gross Profit | 60.16 | 55.13 | 51.92 | 44.28 | 37.74 | 33.1 | Upgrade
|
| Selling, General & Admin | 56.57 | 57.6 | 49.37 | 43.28 | 34.52 | 30.54 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0.2 | - | Upgrade
|
| Operating Expenses | 62.54 | 63.45 | 55.53 | 48.41 | 38.6 | 34.04 | Upgrade
|
| Operating Income | -2.38 | -8.32 | -3.6 | -4.13 | -0.85 | -0.94 | Upgrade
|
| Interest Expense | -0.77 | -2.14 | -2.63 | -0.38 | -0.47 | -0.47 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.03 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.06 | 0.2 | -0.35 | 0.73 | -0.07 | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.04 | -1.04 | -0.46 | 0 | - | 0.11 | Upgrade
|
| EBT Excluding Unusual Items | -4.22 | -11.27 | -7.05 | -3.78 | -1.39 | -1.42 | Upgrade
|
| Other Unusual Items | - | - | - | 0.29 | 0.66 | 2.17 | Upgrade
|
| Pretax Income | -4.22 | -11.27 | -7.05 | -3.5 | -0.73 | 0.75 | Upgrade
|
| Income Tax Expense | 1.78 | 0.97 | 0.82 | 0.93 | 0.35 | 1.19 | Upgrade
|
| Earnings From Continuing Operations | -6 | -12.24 | -7.87 | -4.43 | -1.08 | -0.44 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.13 | -0.01 | -0.11 | -0.68 | Upgrade
|
| Net Income to Company | -6 | -12.24 | -8 | -4.44 | -1.19 | -1.12 | Upgrade
|
| Net Income | -6 | -12.24 | -8 | -4.44 | -1.19 | -1.12 | Upgrade
|
| Net Income to Common | -6 | -12.24 | -8 | -4.44 | -1.19 | -1.12 | Upgrade
|
| Shares Outstanding (Basic) | 180 | 121 | 79 | 79 | 78 | 63 | Upgrade
|
| Shares Outstanding (Diluted) | 180 | 121 | 79 | 79 | 78 | 63 | Upgrade
|
| Shares Change (YoY) | 108.63% | 53.66% | 0.01% | 0.16% | 24.22% | 8.64% | Upgrade
|
| EPS (Basic) | -0.03 | -0.10 | -0.10 | -0.06 | -0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.10 | -0.10 | -0.06 | -0.02 | -0.02 | Upgrade
|
| Free Cash Flow | 0.81 | -7.72 | -7.02 | 0.85 | 0.55 | 3.43 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.06 | -0.09 | 0.01 | 0.01 | 0.05 | Upgrade
|
| Gross Margin | 60.01% | 60.15% | 62.09% | 61.01% | 60.19% | 57.77% | Upgrade
|
| Operating Margin | -2.38% | -9.07% | -4.31% | -5.69% | -1.36% | -1.64% | Upgrade
|
| Profit Margin | -5.99% | -13.36% | -9.57% | -6.11% | -1.90% | -1.95% | Upgrade
|
| Free Cash Flow Margin | 0.81% | -8.42% | -8.39% | 1.17% | 0.88% | 5.98% | Upgrade
|
| EBITDA | -0.54 | -6.49 | -1.98 | -2.7 | 0.63 | 0.3 | Upgrade
|
| EBITDA Margin | -0.54% | -7.08% | -2.37% | -3.72% | 1.00% | 0.53% | Upgrade
|
| D&A For EBITDA | 1.84 | 1.83 | 1.62 | 1.43 | 1.48 | 1.24 | Upgrade
|
| EBIT | -2.38 | -8.32 | -3.6 | -4.13 | -0.85 | -0.94 | Upgrade
|
| EBIT Margin | -2.38% | -9.07% | -4.31% | -5.69% | -1.36% | -1.64% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 158.68% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.